Skip to content

Research on the Efficacy of Computational Modeling-Based Dual-Target TMS in Improving Multi-Task Processing Impairments in Parkinson's Disease

Research on the Efficacy of Computational Modeling-Based Dual-Target TMS in Improving Multi-Task Processing Impairments in Parkinson's Disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600128502
Enrollment
Unknown
Registered
2026-07-21
Start date
2026-09-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's Disease

Interventions

TMS group:Both coils will simultaneously stimulate the left DLPFC and left cerebellum. The stimulation will be administered for 5 consecutive days per week, over two consecutive weeks, totaling 10 ses
TMS-sham group:The coil is positioned at 90 degrees to the head, producing only sound without an effective magnetic field, while all other procedures are identical to those in theTMS group.
Health Group:none

Sponsors

Beijing Rehabilitation Hospital Affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. PD patients: (1) Meet the diagnostic criteria of the Chinese Guidelines for the Treatment of Parkinson's Disease (Third Edition); (2) Hoehn-Yahr stage I–IV; (3) Aged 30–70 years, any gender, right-handed; (4) In the "ON" state, with a stable medication regimen for at least 4 weeks. For stage IV patients, the following additional conditions must be met: 1) Able to walk 10 meters independently or with a walking aid, without requiring physical assistance from others; 2) Able to independently complete tablet-based drawing tasks; 3) No more than 2 falls in the past 3 months. 2. Healthy subjects: (1) Healthy individuals in good physical condition; (2) Aged 30–70 years, any gender.

Exclusion criteria

Exclusion criteria: 1.PD patients: (1) Those with various secondary Parkinson's syndromes and Parkinson's plus syndromes; (2) Dysfunction of vital organs such as the heart, liver, kidneys, or the hematopoietic system, as well as moderate to severe primary diseases of the endocrine system; (3) Severe infections or severe complications of diabetes mellitus; (4) Schizophrenia, Alzheimer's disease, vascular dementia, or cognitive impairment caused by other conditions. 2.Healthy subjects: Those with a history of neurological diseases, severe physical illnesses, or mental disorders.

Design outcomes

Primary

MeasureTime frame
Dual-Task Cost;

Secondary

MeasureTime frame
MDS-UPDRS-III;Digit Symbol Substitution Test;Stroop Color-Word Test;Cognitive-Motor Dual-Task Assessment;Functional magnetic resonance imaging, fMRI;Functional near-infrared spectroscopy, fNIRS;

Countries

China

Contacts

Public ContactHuang Peiling

Beijing Rehabilitation Hospital Affiliated to Capital Medical University

hpl0804928@163.com+86 10 5698 1069

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 10, 2026